Takeda Pharmaceuticals

Cell Genesys, Takeda Pharma suspend further development of GVAX immunotherapy for prostate cancer...

pharmiweb.co.uk
4 hrs ago 7 related
        

Cell Genesys, Takeda Pharma suspend further development of GVAX immunotherapy for prostate cancer - Quick Facts 12/3/2008 8:46 AM ET (RTTNews) - Cell Genesys Inc. (CEGE: News ) and Takeda Pharmaceutical Company Limited,...

add comment
                   

Sucampo Completes Enrollment in Phase 3 Pivotal Studies of Oral Lubiprostone to Treat...

yahoo.com
20 hrs ago 5 related
        

BETHESDA, MD----Sucampo Pharmaceuticals, Inc. today announced that it has completed enrollment and initial dosing of patients in two pivotal phase 3 trials of lubiprostone for the treatment of Opioid-Induced Bowel Dysfunction .

add comment
                   

Antimicrobials the Leading Cause of Drug-Induced Liver Injury

medpagetoday.com
yesterday
        

INDIANAPOLIS, Dec. 2 -- Explain to interested patients that this study found that antimicrobials and central nervous system agents were the two most common causes of drug-induced liver injury in this observational study. Of...

add comment

Takeda to begin Construction of New Research Facilities

pharmiweb.co.uk
yesterday
        

OSAKA, Japan, December 2, 2008 - Takeda Pharmaceutical Company Limited (“Takeda”) today announced that it is to begin construction of new research facilities which straddle the border of the cities of Fujisawa and Kamakura in...

add comment
                   

Lower-cost drugs predicted under Obama administration

chicagotribune.com
30-Nov-2008 97 related
        

Democratic control in D.C. could pave way for initiatives By Bruce Japsen | Tribune reporter Cheaper drugs could be on the way to U.S. consumers under the Barack Obama administration. "We are likely to see some movements with...

add comment
                   

FDA Arthritis Advisory Committee recommends approval for Takeda gout drug

pharmiweb.co.uk
26-Nov-2008 45 related
        

Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients with Gout Deerfield, Ill., and Osaka, Japan, November 24, 2008 – Takeda Pharmaceutical Company Limited and its...

add comment
                   

Avandia's Heart Risk Higher Than Others in Its Class

medicinenet.com
25-Nov-2008 20 related
        

MONDAY, Nov. 24 (HealthDay News) -- The risk of heart failure and death for older diabetics appears greater with Avandia than with Actos , both of which are part of a class of drugs called thiazolidinediones, Harvard University...

add comment
                   

"World Wide Web Health Awards" Exposed as Having Ties to Pharmaceutical Industry

newstarget.com
23-Nov-2008 1 related
        

According to an article posted on the Consumer Reports WebWatch site, the "World Wide Web Health Awards" are administered by a company with major financial ties to the pharmaceutical industry."These days, a number of health...

add comment

Newly Elected Latino Officials Head to Nation's Capital for Public Service Boot Camp

hispanicbusiness.com
21-Nov-2008 6 related
        

LOS ANGELES, Nov. 21 /PRNewswire-USNewswire/ -- The National Association of Latino Elected and Appointed Officials (NALEO) Educational Fund, the nation's preeminent Latino leadership organization, hosted 60 freshman public...

add comment

Amgen, Takeda & Millennium provide update on phase-3 trial of motesanib in patients with NSCLC

pharmiweb.co.uk
21-Nov-2008 23 related
        

Thousand Oaks, California Amgen and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited, announced that enrolment in the phase-3 Monet1 trial evaluating motesanib (AMG 706) in...

add comment
1 2 3 next